{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:12:35Z","timestamp":1791576755308,"version":"4.3.4"},"reference-count":148,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.clindermatol.2004.03.009","type":"journal-article","created":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T18:49:44Z","timestamp":1107197384000},"page":"398-407","source":"Crossref","is-referenced-by-count":69,"title":["Acne: Topical treatment"],"prefix":"10.1016","volume":"22","author":[{"given":"Andrea","family":"Krautheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald P.M.","family":"Gollnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2004.03.009_BIB1","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","article-title":"Current concepts of the pathogenesis of acne","volume":"63","author":"Gollnick","year":"2003","journal-title":"Drugs"},{"issue":"Suppl 3","key":"10.1016\/j.clindermatol.2004.03.009_BIB2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0926-9959.2001.00012.x","article-title":"The integral role of topical and oral retinoids in the early treatment of acne","volume":"15","author":"Shalita","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archfami.9.2.179","article-title":"New treatments and therapeutic strategies for acne","volume":"9","author":"Thiboutot","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB4","series-title":"Acne: diagnosis and management","author":"Cunliffe","year":"2001"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB5","series-title":"Acne and rosacea","author":"Plewig","year":"2002"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB6","first-page":"357","article-title":"Topical therapy for acne","volume":"61","author":"Russell","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000067817","article-title":"Epidemiology of acne","volume":"206","author":"Dreno","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017844","article-title":"Topical drug treatment in acne","volume":"196","author":"Gollnick","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000067820","article-title":"Topical treatment in acne","volume":"206","author":"Gollnick","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB10","doi-asserted-by":"crossref","unstructured":"Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003;42:1287\u20131304","DOI":"10.2165\/00003088-200342140-00005"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(86)70228-4","article-title":"Historical perspectives of tretinoin","volume":"15","author":"Stuttgen","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB12","series-title":"Drug therapy in dermatology","first-page":"171","article-title":"Retinoids","author":"Zouboulis","year":"2000"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2004.03.009_BIB13","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1468-3083.1998.tb00901.x","article-title":"Topical therapy in acne","volume":"11","author":"Gollnick","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000017846","article-title":"An overview of topical antibiotics for acne treatment","volume":"196","author":"Toyoda","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1994.tb08519.x","article-title":"Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients","volume":"131","author":"Eady","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/120347540100500109","article-title":"The efficacy and safety of a combination benzoyl peroxide\/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide\/erythromycin combination product","volume":"5","author":"Leyden","year":"2001","journal-title":"J Cutan Med Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2004.03.009_BIB18","first-page":"5","article-title":"Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction","volume":"67","author":"Leyden","year":"2001","journal-title":"Cutis"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2004.03.009_BIB19","first-page":"25","article-title":"Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris","volume":"67","author":"Tschen","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000029936","article-title":"Synergistic activity of benzoyl peroxide and erythromycin","volume":"13","author":"Burkhart","year":"2000","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2230.1989.tb02584.x","article-title":"A double-blind clinical trial with a lotion containing 5% benzoyl peroxide and 2% miconazole in patients with acne vulgaris","volume":"14","author":"Mesquita-Guimaraes","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB22","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1067\/mjd.2000.108318","article-title":"Combination azelaic acid therapy for acne vulgaris","volume":"43","author":"Webster","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB23","first-page":"353","article-title":"The treatment of acne","volume":"28","author":"Gollnick","year":"1992","journal-title":"Drugs Today"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB24","first-page":"257","article-title":"Clinico-experimental studies on the effect of benzoylperoxide [in German]","volume":"33","author":"Puschmann","year":"1982","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2133.1983.tb03990.x","article-title":"Beneficial effect of 15% azelaic acid cream on acne vulgaris","volume":"109","author":"Nazzaro-Porro","year":"1983","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2004.03.009_BIB26","first-page":"20","article-title":"Efficacy and safety of topical azelaic acid (20 percent cream)","volume":"57","author":"Graupe","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB27","first-page":"975","article-title":"Azelains\u00e4ure f\u00fcr die behandlung der kkne","volume":"67","author":"Gollnick","year":"1992","journal-title":"Z Hautkr"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB28","first-page":"40","article-title":"Long-term treatment of acne with 20% azelaic acid cream","volume":"143","author":"Cavicchini","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB29","first-page":"35","article-title":"Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin","volume":"143","author":"Katsambas","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0190-9622(84)80466-1","article-title":"Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids","volume":"11","author":"Van Scott","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB31","first-page":"279","article-title":"The modern age of acne therapy","volume":"68","author":"Bershad","year":"2001","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00128071-200001020-00002","article-title":"Alpha-hydroxy acid-based cosmetic procedures. Guidelines for patient management","volume":"1","author":"Tung","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1523-1747.1998.00080.x","article-title":"Evidence of heterogeneity and quantitative differences of the type 1 5 \u03b1-reductase expression in cultured human skin cells\u2014evidence of its presence in melanocytes","volume":"110","author":"Chen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000246242","article-title":"The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders","volume":"193","author":"Chen","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00128071-200203080-00007","article-title":"Acne","volume":"3","author":"Shaw","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2133.2000.03528.x","article-title":"Phototherapy and acne vulgaris","volume":"142","author":"Cunliffe","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0738-081X(97)00013-8","article-title":"Retinoids","volume":"15","author":"Gollnick","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","article-title":"Current use and future potential role of retinoids in dermatology","volume":"53","author":"Orfanos","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2133.2001.04276.x","article-title":"Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents","volume":"145","author":"Thielitz","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB40","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mjd.2003.618","article-title":"for the Global Alliance to Improve Outcomes in Acne. Management of acne","volume":"49","author":"Gollnick","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0968-0004(92)90014-Z","article-title":"Multiplicity generates diversity in the retinoic acid signalling pathways","volume":"17","author":"Leid","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000056361","article-title":"Retinoids\u2014which dermatological indications will benefit in the near future?","volume":"14","author":"Zouboulis","year":"2001","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB43","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/1381612003400146","article-title":"Recent developments in receptor-selective retinoids","volume":"6","author":"Nagpal","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00370719","article-title":"Human in vivo pharmacology of topical retinoids","volume":"287","author":"Griffiths","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB45","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0190-9622(98)70313-5","article-title":"Future trends","volume":"39","author":"Chandraratna","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB46","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1128\/MCB.17.7.4159","article-title":"Retinoid antagonism of NF-IL6","volume":"17","author":"Nagpal","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1074\/jbc.270.2.923","article-title":"Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha","volume":"270","author":"Nagpal","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB48","series-title":"Drug therapy in dermatology","first-page":"171","article-title":"Retinoids","author":"Zouboulis","year":"2000"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02850266","article-title":"Potential anti-inflammatory effects of topical retinoids and retinoid analogues","volume":"19","author":"Wolf","year":"2002","journal-title":"Adv Ther"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1346-8138.2003.tb00402.x","article-title":"Retinoids","volume":"30","author":"Sardana","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJM198510033131401","article-title":"Retinoic acid embryopathy","volume":"313","author":"Lammer","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB52","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/0140-6736(93)90868-H","article-title":"Multiple congenital defects associated with maternal use of topical tretinoin","volume":"341","author":"Lipson","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB53","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0140-6736(92)90854-V","article-title":"Ear malformation in baby born to mother using tretinoin cream","volume":"339","author":"Camera","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB54","series-title":"Retinoids in clinical practice","first-page":"77","article-title":"Retinoid embryopathy in humans","author":"Rosa","year":"1992"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0140-6736(93)91004-6","article-title":"First trimester topical tretinoin and congenital disorders","volume":"341","author":"Jick","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB56","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(97)70063-X","article-title":"A physiologically based pharmacokinetic model for retinoic acid and its metabolites","volume":"36","author":"Clewell","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2004.03.009_BIB57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000211162","article-title":"Embryotoxicity and teratogenicity of topical retinoic acid","volume":"6","author":"Nau","year":"1993","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB58","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0190-9622(98)70459-1","article-title":"Retinoids and teratogenicity","volume":"39","author":"Jick","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB59","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0190-9622(98)70142-2","article-title":"Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris","volume":"38","author":"Lucky","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB60","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0190-9622(98)70141-0","article-title":"Comparative efficacy and safety of two 0.025% tretinoin gels","volume":"38","author":"Lucky","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB61","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/js9604568","article-title":"Topical delivery system for tretinoin","volume":"86","author":"Skov","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB62","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0190-9622(98)70139-2","article-title":"Reduced skin irritation with tretinoin containing polyolprepolymer-2, a new topical tretinoin delivery system","volume":"38","author":"Quigley","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB63","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/02652049609026042","article-title":"The microsponge delivery system (MDS)","volume":"13","author":"Embil","year":"1996","journal-title":"J Microencapsul"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB64","first-page":"17","article-title":"Randomized facial tolerability studies comparing gel formulations of retinoids used to treat acne vulgaris","volume":"67","author":"Leyden","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB65","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/BF00577761","article-title":"Liposomal tretinoin for uncomplicated acne vulgaris","volume":"72","author":"Schafer-Korting","year":"1994","journal-title":"Clin Invest"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/sder.2001.27555","article-title":"Developments in topical retinoid therapy for acne","volume":"20","author":"Bershad","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB67","first-page":"295","article-title":"The stability of tretinoin in tretinoin gel microsphere 0.1%","volume":"70","author":"Nyirady","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB68","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2133.1989.tb01349.x","article-title":"Isotretinoin differs from other synthetic retinoids in its modulation of human cellular retinoic acid binding protein (CRABP)","volume":"120","author":"Hirschel-Scholz","year":"1989","journal-title":"Br J Dermatol"},{"issue":"Suppl 3","key":"10.1016\/j.clindermatol.2004.03.009_BIB69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.0926-9959.2001.00015.x","article-title":"Exploration of retinoid activity and the role of inflammation in acne","volume":"15","author":"Zouboulis","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB70","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000211477","article-title":"Sebaceous-gland deposition of isotretinoin after topical application","volume":"10","author":"Tschan","year":"1997","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00417712","article-title":"Influence on oral isotretinoin treatment on the composition of comedonal lipids. Implications for comedogenesis in acne vulgaris","volume":"280","author":"Melnik","year":"1988","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB72","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0190-9622(97)70050-1","article-title":"Pharmacology and chemistry of adapalene","volume":"36","author":"Shroot","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 52","key":"10.1016\/j.clindermatol.2004.03.009_BIB73","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x","article-title":"A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris","volume":"139","author":"Cunliffe","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB74","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2133.2002.04873.x","article-title":"Topical adapelene gel 0.1% vs isotretinoin gel 0.5% in the treatment of acne vulgaris","volume":"14","author":"Ioannides","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB75","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0190-9622(98)70440-2","article-title":"Pharmacodynamics and pharmacokinetics of topical adapalene","volume":"39","author":"Shroot","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 52","key":"10.1016\/j.clindermatol.2004.03.009_BIB76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2133.1998.1390s2026.x","article-title":"Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life","volume":"139","author":"Grosshans","year":"1998","journal-title":"Br J Dermatol"},{"issue":"Suppl 52","key":"10.1016\/j.clindermatol.2004.03.009_BIB77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1365-2133.1998.1390s2012.x","article-title":"Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor\u2013mediated gene transcription without significant irritative effects in the skin of healthy human volunteers","volume":"139","author":"Griffiths","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB78","first-page":"243","article-title":"Efficacy and cutaneous safety of adapalene in black patients versus white patients with acne vulgaris","volume":"70","author":"Czernielewski","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB79","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1365-4362.2000.00050.x","article-title":"Adapalene","volume":"39","author":"Millikan","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB80","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-199753030-00010","article-title":"Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne","volume":"53","author":"Brogden","year":"1997","journal-title":"Drugs"},{"issue":"Suppl","key":"10.1016\/j.clindermatol.2004.03.009_BIB81","doi-asserted-by":"crossref","first-page":"487s","DOI":"10.1016\/S0223-5234(23)00147-2","article-title":"Pharmacology of retinoids in the skin","volume":"30","author":"Shroot","year":"1995","journal-title":"Eur J Med Chem"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2004.03.009_BIB82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000211165","article-title":"Adapalene, a new chemical entity with retinoid activity","volume":"6","author":"Bernard","year":"1993","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00003088-199937040-00001","article-title":"Clinical pharmacokinetics and drug metabolism of tazarotene","volume":"37","author":"Tang-Liu","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB84","first-page":"1","article-title":"Topical tazarotene therapy for psoriasis, acne vulgaris, and photoaging","volume":"7","author":"Guenther","year":"2002","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00003495-199855050-00008","article-title":"Tazarotene","volume":"55","author":"Foster","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB86","first-page":"349","article-title":"Tazarotene gel is safe and effective in the treatment of acne vulgaris","volume":"63","author":"Shalita","year":"1999","journal-title":"Cutis"},{"issue":"Suppl 6","key":"10.1016\/j.clindermatol.2004.03.009_BIB87","first-page":"10","article-title":"Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel","volume":"67","author":"Leyden","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB88","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1067\/mjd.2000.108322","article-title":"Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris","volume":"43","author":"Kakita","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB89","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archderm.138.4.481","article-title":"Successful treatment of acne vulgaris using a new method","volume":"138","author":"Bershad","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB90","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00003495-198734040-00003","article-title":"The retinoids. A review of their clinical pharmacology and therapeutic use","volume":"34","author":"Orfanos","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000066240","article-title":"Topical retinoyl \u03b2-glucuronide is an effective treatment of mild to moderate acne vulgaris in Asian-Indian patients","volume":"12","author":"Goswami","year":"1999","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/09546639409080563","article-title":"Retinoyl \u03b2-glucuronide","volume":"5","author":"Gunning","year":"1994","journal-title":"J Dermatol Treat"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2004.03.009_BIB93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051376","article-title":"Comedolytic effect of topical retinaldehyde in the rhino mouse model","volume":"199","author":"Fort-Lacoste","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB94","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2230.1999.00499.x","article-title":"Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris","volume":"24","author":"Morel","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000063903","article-title":"The antibacterial activity of topical retinoids","volume":"205","author":"Pechere","year":"2002","journal-title":"Dermatology"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2004.03.009_BIB96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000051371","article-title":"What are natural retinoids?","volume":"199","author":"Vahlquist","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB97","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000017846","article-title":"An overview of topical antibiotics for acne treatment","volume":"196","author":"Toyoda","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB98","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0190-9622(84)70139-3","article-title":"Acne treatment with topical erythromycin and zinc","volume":"11","author":"Strauss","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB99","first-page":"339","article-title":"Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels","volume":"31","author":"Puhvel","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB100","series-title":"Topical antibiotics in acne","first-page":"127","article-title":"Topical erythromycin in clinical and laboratory studies","author":"Cunliffe","year":"1989"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB101","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1542\/peds.62.6.1044","article-title":"Acne","volume":"62","author":"Esterly","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1099\/00222615-20-1-11","article-title":"The pathological and ecological significance of microorganisms colonizing acne vulgaris comedones","volume":"20","author":"Leeming","year":"1985","journal-title":"J Med Microbiol"},{"issue":"Suppl 3","key":"10.1016\/j.clindermatol.2004.03.009_BIB103","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0926-9959.2001.00013.x","article-title":"Current issues in antimicrobial therapy for the treatment of acne","volume":"15","author":"Leyden","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB104","first-page":"25","article-title":"Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris","volume":"9","author":"Kurokawa","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000067822","article-title":"Propionibacterium acnes resistance","volume":"206","author":"Eady","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB106","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB107","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00128071-200102040-00007","article-title":"The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB108","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/120347540100500109","article-title":"The efficacy and safety of a combination benzoyl peroxide\/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide\/erythromycin combination product","volume":"5","author":"Leyden","year":"2001","journal-title":"J Cutan Med Surg"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2004.03.009_BIB109","first-page":"5","article-title":"Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction","volume":"67","author":"Leyden","year":"2001","journal-title":"Cutis"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2004.03.009_BIB110","first-page":"25","article-title":"Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris","volume":"67","author":"Tschen","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000029936","article-title":"Synergistic activity of benzoyl peroxide and erythromycin","volume":"13","author":"Burkhart","year":"2000","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2230.1989.tb02584.x","article-title":"A double-blind clinical trial with a lotion containing 5% benzoyl peroxide and 2% miconazole in patients with acne vulgaris","volume":"14","author":"Mesquita-Guimaraes","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB113","first-page":"475","article-title":"Effect of topical benzoyl peroxide\/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes","volume":"69","author":"Leyden","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB114","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1067\/mjd.2000.108318","article-title":"Combination azelaic acid therapy for acne vulgaris","volume":"43","author":"Webster","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archderm.112.2.182","article-title":"Topically applied antibiotics in acne vulgaris","volume":"112","author":"Resh","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB116","first-page":"551","article-title":"Topical clindamycin in the control of acne vulgaris","volume":"17","author":"Stoughton","year":"1976","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0190-9622(82)80009-1","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of acne. Results of a multiclinic trial","volume":"7","author":"Gratton","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB118","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archderm.117.8.482","article-title":"Topical clindamycin therapy for acne vulgaris. A cooperative clinical study","volume":"117","author":"Becker","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB119","first-page":"424","article-title":"Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg\/day in the treatment of acne vulgaris","volume":"26","author":"Stoughton","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB120","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0190-9622(85)70074-6","article-title":"An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris","volume":"12","author":"Lesher","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB121","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0190-9622(80)80044-2","article-title":"Topically applied erythromycin in inflammatory acne vulgaris","volume":"2","author":"Bernstein","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB122","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/archderm.110.1.83","article-title":"Topical antibacterial therapy for acne. Study of the family of erythromycins","volume":"110","author":"Fulton","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB123","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0934-8840(99)80084-X","article-title":"In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin","volume":"289","author":"Fluhr","year":"1999","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB124","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.1994.tb02929.x","article-title":"Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc","volume":"130","author":"Bojar","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00192359","article-title":"A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex","volume":"49","author":"Pierard-Franchimont","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB126","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2230.1993.tb02238.x","article-title":"Effect of a topical erythromycin\u2013zinc formulation on sebum delivery. Evaluation by combined photometric\u2013multi-step samplings with Sebutape","volume":"18","author":"Pierard","year":"1993","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB127","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle","volume":"82","author":"Mills","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB128","first-page":"242","article-title":"Overview of treatments for acne","volume":"14","author":"Oprica","year":"2002","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0149-2918(02)85151-7","article-title":"A randomized, parallel, vehicle-controlled comparison of two erythromycin\/benzoyl peroxide preparations for acne vulgaris","volume":"24","author":"Thiboutot","year":"2002","journal-title":"Clin Ther"},{"issue":"Suppl","key":"10.1016\/j.clindermatol.2004.03.009_BIB130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2340\/00015555895763","article-title":"Benzoyl peroxide","volume":"89","author":"Cotterill","year":"1980","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB131","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000249352","article-title":"Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris","volume":"172","author":"Fyrand","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB132","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-4362.1986.tb04534.x","article-title":"Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris","volume":"25","author":"Mills","year":"1986","journal-title":"Int J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.clindermatol.2004.03.009_BIB133","first-page":"13","article-title":"Therapeutic studies with a new combination benzoyl peroxide\/clindamycin topical gel in acne vulgaris","volume":"67","author":"Ellis","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB134","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","article-title":"Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy","volume":"126","author":"Harkaway","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB136","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.1984.tb04664.x","article-title":"Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris","volume":"110","author":"Tucker","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB137","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0190-9622(83)70211-2","article-title":"A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris","volume":"9","author":"Chalker","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB138","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A randomized, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB139","first-page":"53","article-title":"The effect of benzoyl peroxide and benzoyl peroxide\/erythromycin combination on the antioxidative defence system in papulopustular acne","volume":"12","author":"Basak","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archderm.121.1.55","article-title":"Topical antiandrogens. What use in dermatology?","volume":"121","author":"Lucky","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB141","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archderm.128.9.1197","article-title":"Inocoterone and acne. The effect of a topical antiandrogen","volume":"128","author":"Lookingbill","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB142","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.134.4.459","article-title":"Topical cyproterone acetate treatment in women with acne","volume":"134","author":"Gruber","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB143","first-page":"247","article-title":"Treatment of acne vulgaris with salicylic acid pads","volume":"14","author":"Zander","year":"1992","journal-title":"Clin Ther"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB144","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1006\/bbrc.1996.0937","article-title":"Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation","volume":"223","author":"Arakane","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000067824","article-title":"Less common methods to treat acne","volume":"206","author":"Kaminsky","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB146","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2133.2000.03528.x","article-title":"Phototherapy and acne vulgaris","volume":"142","author":"Cunliffe","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB147","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2133.2000.03481.x","article-title":"Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris","volume":"142","author":"Papageorgiou","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2004.03.009_BIB148","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2133.1999.03083.x","article-title":"Light cautery of macrocomedones under general anaesthesia","volume":"141","author":"Thomson","year":"1999","journal-title":"Br J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T22:17:30Z","timestamp":1682979450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X04000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0738081X04000422"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2004.03.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}